Mark Turner

A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes

2022 | Ústřední knihovna, 1. lékařská fakulta

Publikace